Current trials on angiotensin-converting enzyme inhibitors and endothelial dysfunction.
Several mechanisms are thought to play a role in the improvement in endothelial vasodilation produced by angiotensin-converting enzyme inhibitors. Both animal and clinical data are reviewed.
University of Calgary, Alberta. todd.anderson@health.ab.ca
T
T
Anderson
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology*; D003327:Coronary Disease / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology*; D006801:Humans; D014664:Vasodilation / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D001920:Bradykinin